We want to learn more about Enterotoxigenic Escherichia coli (ETEC), a common bacterial cause of diarrhea worldwide. Knowledge from this study may be helpful in developing ETEC vaccines in the future.
Adults 18 to 49 years old who are generally in good health.
This study includes approximately 10 clinic visits, an inpatient stay for up to 10 days, and 2 phone calls over a 10-month period.
Here are some of the things that will happen in this study:
You will:
During the stay in the extended stay research unit, study staff will be available at all times to care for you.
Adults interested in participating in this study will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.
There is no direct benefit to you for participating in this study. However, when we complete the study, we hope to know more about ETEC infections which may be helpful in developing future ETEC vaccines.
Possible risks and discomforts will be discussed with those interested in learning more about the study.
Participants may receive up to $5,021 to complete the study over 10 months.
Robert Frenck
Infectious Diseases
Cincinnati Children's Hospital Medical Center